Certara to Participate in Upcoming Investor Conferences
RADNOR, Pa., 2026 年 5 月 18 日 (GLOBE NEWSWIRE) -- Certara, Inc. （纳斯达克股票代码：CERT), a global leader…
Certara2026 年 5 月 18 日
Certara Reports First Quarter 2026 Financial Results
RADNOR, Pa., 2026 年 5 月 11 日 (GLOBE NEWSWIRE) -- Certara, Inc. （纳斯达克股票代码：CERT), a global leader…
Certara2026 年 5 月 11 日
Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development
LAVAL, Québec, and Radnor, PA — 2026 年 5 月 7 日 — Altasciences, a fully integrated drug…
Certara2026 年 5 月 7 日
Certara Enters Definitive Agreement for the Sale of its Regulatory Writing and Medical Writing Business to Veristat
Transaction sharpens focus on Model-Informed Drug Development (MIDD) and Clinical Intelligence Updated 2026 guidance to…
Certara2026 年 4 月 22 日
Certara to Report First Quarter 2026 Financial Results on May 11th, 2026
Radnor, Pa. — 2026 年 4 月 9 日 -- Certara, Inc. （纳斯达克股票代码：CERT), a global leader in…
Danielle Pillsbury2026 年 4 月 9 日
Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib
Novartis used PBPK modeling for therapeutic regulatory success. They used model simulations to replace clinical…
Certara2026 年 3 月 3 日
Certara to Participate in Upcoming Investor Conferences
RADNOR, PA – 2026 年 2 月 27 日 -- Certara, Inc. （纳斯达克股票代码：CERT), a global leader in…
Certara2026 年 2 月 27 日
Certara Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Guidance
FY 2025 Revenue of $418.8M (9% growth) and Adj. EBITDA of $134.5M (10% growth) Fourth…
Certara2026 年 2 月 26 日
Certara to Report Fourth Quarter and Full Year 2025 Financial Results on February 26th, 2026
Radnor, Pa. — 2026 年 1 月 29 日 -- Certara, Inc. （纳斯达克股票代码：CERT), a global leader in…
Certara2026 年 1 月 29 日
Certara Appoints Jon Resnick as Chief Executive Officer
Resnick brings decades of leadership experience in health sciences, business operations, strategy, innovation and commercial…
Certara2025 年 12 月 11 日
